ADC adds second ADC to Synaffix deal

ADC Therapeutics S.A. (Epalinges, Switzerland) exercised its option under a 2016 deal to use GlycoConnect and HydraSpace antibody-drug conjugate (ADC) technologies from Synaffix B.V. (Oss, the Nethe...